These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 35034333)

  • 1. The frequency of ALSFRS-R reversals and plateaus in patients with limb-onset amyotrophic lateral sclerosis: a cohort study.
    Hu N; Shen D; Yang X; Cui L; Liu M
    Acta Neurol Belg; 2022 Dec; 122(6):1567-1573. PubMed ID: 35034333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plateaus and reversals evaluated by different methods in patients with limb-onset amyotrophic lateral sclerosis.
    Hu N; Shen D; Yang X; Cui L; Liu M
    J Clin Neurosci; 2022 Mar; 97():93-98. PubMed ID: 35074582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How common are ALS plateaus and reversals?
    Bedlack RS; Vaughan T; Wicks P; Heywood J; Sinani E; Selsov R; Macklin EA; Schoenfeld D; Cudkowicz M; Sherman A
    Neurology; 2016 Mar; 86(9):808-12. PubMed ID: 26658909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal comparison of the self-entry Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-RSE) and Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) as outcome measures in people with amyotrophic lateral sclerosis.
    Johnson SA; Burke KM; Scheier ZA; Keegan MA; Clark AP; Chan J; Fournier CN; Berry JD
    Muscle Nerve; 2022 Oct; 66(4):495-502. PubMed ID: 35904151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.
    ;
    Lancet Neurol; 2017 Jul; 16(7):505-512. PubMed ID: 28522181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plateaus in amyotrophic lateral sclerosis progression: results from a population-based cohort.
    Vasta R; D'Ovidio F; Canosa A; Manera U; Torrieri MC; Grassano M; De Marchi F; Mazzini L; Moglia C; Calvo A; Chiò A
    Eur J Neurol; 2020 Aug; 27(8):1397-1404. PubMed ID: 32346913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the measurement properties of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R): deriving a valid measurement total for the calculation of change.
    Young CA; Chaouch A; Mcdermott CJ; Al-Chalabi A; Chhetri SK; Talbot K; Malaspina A; Mills R; Tennant A
    Amyotroph Lateral Scler Frontotemporal Degener; 2024 May; 25(3-4):400-409. PubMed ID: 38426231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using the ALSFRS-R in multicentre clinical trials for amyotrophic lateral sclerosis: potential limitations in current standard operating procedures.
    Bakers JNE; de Jongh AD; Bunte TM; Kendall L; Han SS; Epstein N; Lavrov A; Beelen A; Visser-Meily JMA; van den Berg LH; van Eijk RPA
    Amyotroph Lateral Scler Frontotemporal Degener; 2022 Nov; 23(7-8):500-507. PubMed ID: 34949141
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessing upper limb function with ALSFRS-R in amyotrophic lateral sclerosis patients.
    Pinto S; Gromicho M; de Carvalho M
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 Aug; 20(5-6):445-448. PubMed ID: 31032642
    [No Abstract]   [Full Text] [Related]  

  • 10. The MITOS system predicts long-term survival in amyotrophic lateral sclerosis.
    Tramacere I; Dalla Bella E; Chiò A; Mora G; Filippini G; Lauria G;
    J Neurol Neurosurg Psychiatry; 2015 Nov; 86(11):1180-5. PubMed ID: 25886781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient reported outcomes in ALS: characteristics of the self-entry ALS Functional Rating Scale-revised and the Activities-specific Balance Confidence Scale.
    Chew S; Burke KM; Collins E; Church R; Paganoni S; Nicholson K; Babu S; Scalia JB; De Marchi F; Ellrodt AL; Moura LMVR; Chan J; Berry JD
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 Nov; 22(7-8):467-477. PubMed ID: 33771057
    [No Abstract]   [Full Text] [Related]  

  • 12. Remote digital assessment of amyotrophic lateral sclerosis functional rating scale - a multicenter observational study.
    Meyer T; Spittel S; Grehl T; Weyen U; Steinbach R; Kettemann D; Petri S; Weydt P; Günther R; Baum P; Schlapakow E; Koch JC; Boentert M; Wolf J; Grosskreutz J; Rödiger A; Ilse B; Metelmann M; Norden J; Koc RY; Körtvélyessy P; Riitano A; Walter B; Hildebrandt B; Schaudinn F; Münch C; Maier A
    Amyotroph Lateral Scler Frontotemporal Degener; 2023 May; 24(3-4):175-184. PubMed ID: 35912984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of disease progression rate and related factors in amyotrophic lateral sclerosis patients at initial visit].
    Zhang JH; Wang HF; Yang F; He ZQ; Feng F; Li M; Bai JM; Wang HR; Huang XS
    Zhonghua Yi Xue Za Zhi; 2022 Jan; 102(3):222-227. PubMed ID: 35042292
    [No Abstract]   [Full Text] [Related]  

  • 14. Association between nutritional status and disease severity using the amyotrophic lateral sclerosis (ALS) functional rating scale in ALS patients.
    Park Y; Park J; Kim Y; Baek H; Kim SH
    Nutrition; 2015; 31(11-12):1362-7. PubMed ID: 26429656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between the ALSFRS-R score and urate levels during 12 months of edaravone treatment for amyotrophic lateral sclerosis: Post hoc analysis of ALSFRS-R scores in clinical studies MCI186-16, MCI186-17, and MCI186-19.
    Takahashi F; Kano O; Nagano Y; Yoneoka T; Nelson S; Ushirogawa Y
    Muscle Nerve; 2022 Nov; 66(5):593-602. PubMed ID: 36053970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multipoint incremental motor unit number estimation versus amyotrophic lateral sclerosis functional rating scale and the medical research council sum score as an outcome measure in amyotrophic lateral sclerosis.
    Jagtap SA; Kuruvilla A; Govind P; Nair MD; Sarada C; Varma RP
    Ann Indian Acad Neurol; 2014 Jul; 17(3):336-9. PubMed ID: 25221407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Validation of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS).
    Fournier CN; Bedlack R; Quinn C; Russell J; Beckwith D; Kaminski KH; Tyor W; Hertzberg V; James V; Polak M; Glass JD
    JAMA Neurol; 2020 Apr; 77(4):480-488. PubMed ID: 31886839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of the characteristics of patients with amyotrophic lateral sclerosis with neuromuscular junction dysfunction prior to motor neuron degeneration].
    Zhang JH; Chen ZH; Ling L; Cheng HM; Zhang Y; Zhao JR; Huang XS
    Zhonghua Nei Ke Za Zhi; 2024 Jul; 63(7):660-665. PubMed ID: 38951089
    [No Abstract]   [Full Text] [Related]  

  • 19. Sensitivity and specificity of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised to detect dysarthria in individuals with amyotrophic lateral sclerosis.
    Donohue C; Chapin JL; Anderson A; DiBiase L; Gray LT; Wymer JP; Plowman EK
    Muscle Nerve; 2023 Sep; 68(3):296-302. PubMed ID: 37345346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity in ALSFRS-R decline and survival: a population-based study in Italy.
    Mandrioli J; Biguzzi S; Guidi C; Sette E; Terlizzi E; Ravasio A; Casmiro M; Salvi F; Liguori R; Rizzi R; Pietrini V; Borghi A; Rinaldi R; Fini N; Chierici E; Santangelo M; Granieri E; Mussuto V; De Pasqua S; Georgoulopoulou E; Fasano A; ; Ferro S; D'Alessandro R
    Neurol Sci; 2015 Dec; 36(12):2243-52. PubMed ID: 26205535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.